[SCHEDULE 13G] Mobia Medical, Inc. Passive Investment Disclosure (>5%)
Mobia Medical: Synapse reports 1.99M shares (6%)
Mobia Medical, Inc. disclosure: Synapse Investment and related entities report beneficial ownership of 1,986,072 shares of Common Stock, equal to 6.0% of the class.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Mobia Medical, Inc. disclosure: Synapse Investment and related entities report beneficial ownership of 1,986,072 shares of Common Stock, equal to 6.0% of the class. The filing states these holders share voting and dispositive power over the reported shares.
The reporting parties list their principal business office as c/o SR One Capital Management, LP, Redwood City, CA, and the report was signed pursuant to a power of attorney.
Key Figures
Shares beneficially owned:1,986,072 sharesPercent of class:6.0%CUSIP:60705V103
3 metrics
Shares beneficially owned1,986,072 sharesreported on Schedule 13G cover lines
Percent of class6.0%reported on Schedule 13G cover lines
CUSIP60705V103Common Stock, $0.01 par value per share
Key Terms
Schedule 13G, Beneficial ownership, Shared dispositive power, Power of Attorney
4 terms
Schedule 13Gregulatory
"Item 1. Name of issuer: Mobia Medical, Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownershipfinancial
"Item 4. Ownership (a) Amount beneficially owned: The information in Items 1 and 5 through 11"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared dispositive powerfinancial
"Line 8 | Shared Dispositive Power 1,986,072.00"
Power of Attorneylegal
"Comments accompanying signature: executed by Sasha Keough pursuant to a Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Mobia Medical (MOBI) shares does Synapse report owning?
Synapse Investment and related entities report beneficial ownership of 1,986,072 shares, representing 6.0% of the common stock. This figure appears on the cover lines of the Schedule 13G and is the ownership amount the filing discloses.
Which entities and individuals are named in the Schedule 13G for MOBI?
The filing names Synapse Investment, Synapse Investment Partners I, Synapse Investment Partners, LLC, and Simeon George, M.D.. Partners I is the general partner of Synapse; Partners is the sole general partner of Partners I.
What voting or dispositive power do the reporting persons claim over MOBI shares?
The reporting persons disclose 0 sole voting and dispositive power and 1,986,072 shared voting and shared dispositive power over the reported shares, as shown on the cover-page lines incorporated into Item 4.
Where is the reporting person's principal business address listed in the filing?
The filing lists the principal business office as c/o SR One Capital Management, LP, 929 Main Street, Suite 200, Redwood City, CA 94063, which is provided for each Reporting Person in Item 2(b).
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Mobia Medical, Inc.
(Name of Issuer)
Common Stock, $0.01 par value per share
(Title of Class of Securities)
60705V103
(CUSIP Number)
05/11/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
60705V103
1
Names of Reporting Persons
Synapse Investment, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,986,072.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,986,072.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,986,072.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
60705V103
1
Names of Reporting Persons
Synapse Investment Partners I, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,986,072.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,986,072.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,986,072.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.0 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
60705V103
1
Names of Reporting Persons
Synapse Investment Partners, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,986,072.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,986,072.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,986,072.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.0 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
60705V103
1
Names of Reporting Persons
Simeon George
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,986,072.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,986,072.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,986,072.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.0 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Mobia Medical, Inc.
(b)
Address of issuer's principal executive offices:
2802 Flintrock Trace, Suite 226, Austin, TX 78738
Item 2.
(a)
Name of person filing:
Synapse Investment, LP ("Synapse"); Synapse Investment Partners I, LP ("Partners I"); Synapse Investment Partners, LLC ("Partners"); and Simeon George, M.D. ("Dr. George").
Partners I is the general partner of Synapse. Partners is the sole general partner of Partners I. Dr. George is the managing member of Partners. Partners I, Partners, and Dr. George share voting and dispositive power with respect to the securities directly held by Synapse.
The persons named in this Item 2(a) are referred to individually herein as a "Reporting Person" and collectively as the "Reporting Persons."
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each Reporting Person is c/o SR One Capital Management, LP, 929 Main Street, Suite 200, Redwood City, CA 94063.
(c)
Citizenship:
Synapse and Partners I are each limited partnerships organized under the laws of the State of Delaware. Partners is a limited liability company organized under the laws of the State of Delaware. Dr. George is a United States citizen.
(d)
Title of class of securities:
Common Stock, $0.01 par value per share
(e)
CUSIP Number(s):
60705V103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information in Items 1 and 5 through 11 on the cover page for each Reporting Person of this Schedule 13G is hereby incorporated by reference.
(b)
Percent of class:
See Line 11 of cover sheets.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Line 5 of cover sheets.
(ii) Shared power to vote or to direct the vote:
See Line 6 of cover sheets.
(iii) Sole power to dispose or to direct the disposition of:
See Line 7 of cover sheets.
(iv) Shared power to dispose or to direct the disposition of:
See Line 8 of cover sheets.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Synapse Investment, LP
Signature:
/s/ Sasha Keough
Name/Title:
Sasha Keough, General Counsel and Chief Compliance Officer
Date:
05/18/2026
Synapse Investment Partners I, LP
Signature:
/s/ Sasha Keough
Name/Title:
Sasha Keough, General Counsel and Chief Compliance Officer
Date:
05/18/2026
Synapse Investment Partners, LLC
Signature:
/s/ Sasha Keough
Name/Title:
Sasha Keough, General Counsel and Chief Compliance Officer
Date:
05/18/2026
Simeon George
Signature:
/s/ Sasha Keough
Name/Title:
Sasha Keough, as attorney-in-fact for Simeon George
Date:
05/18/2026
Comments accompanying signature: This Schedule 13G was executed by Sasha Keough on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2.
Exhibit Information
Exhibit 1 - Agreement regarding filing of joint Schedule 13G.
Exhibit 2 - Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended.
